The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,810.00
Bid: 1,811.00
Ask: 1,811.50
Change: 0.00 (0.00%)
Spread: 0.50 (0.028%)
Open: 1,805.00
High: 1,812.50
Low: 1,797.00
Prev. Close: 1,810.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK MIDDAY BRIEFING: Property Companies Get Indigestion

Fri, 13th Jun 2014 11:29

LONDON (Alliance News) - UK residential and commercial property companies are among the biggest fallers in a declining market Friday, after Bank of England Governor Mark Carney said the interest rates in the UK could rise sooner than investors expect and Chancellor of the Exchequer George Osborne said he would give the central bank more power to curb mortgage lending.

There is already great speculation about the exact timing of the first rate hike and this decision is becoming more balanced, Carney said at the annual Mansion House dinner in London on Thursday evening. Osborne said his move to empower the bank was to limit risk to financial stability from the housing market.

Among the housebuilders, Persimmon was down 6.1%, Barratt Development, down 5.4%, Taylor Wimpey was down 7.1%, Berkeley Group Holdings down 6.1%, Bellway down 5.1% and Bovis Homes was down 4.7%, while Segro, down 4.0%, and Great Portland Estates, down 3.9%, were the worst hit of the real estate investment trusts.

The main London stock indices are again sharply lower due to increasing tensions in Iraq. Oil prices have risen again.

Sunni militants have captured at least one town in eastern Iraq, broadening their domination over portions of the country as they press south toward the capital Baghdad, reports said. Their lightning advances have sparked international fears that Iraq is falling apart, making room for the emergence of a radical enclave.

--------
FTSE 100: down 1.2% at 6,760.34
FTSE 250: down 2.2% at 15,773.43
AIM ALL-SHARE: down 0.9% at 788.14
GBP-USD: up at 1.6950
EUR-USD: down at 1.3533
GOLD: flat at USD1,272.59 an ounce
OIL (Brent): up at USD112.85 a barrel
--------
Other Top UK Corporate News
--------
Petra Diamonds shares jumped to the top of the FTSE 250 index after the company said it has recovered another exceptional 122.52 carat blue diamond at the Cullinan mine in South Africa. The diamond mining company with operations in Tanzania, Botswana and South Africa said the stone will require further analysis in order to assess its potential value, but once this is completed, it will make a decision on a sale plan for the stone. It said that the diamond will therefore not be sold until after the end of the company's current financial year, which ends on June 30.
----------
Tullow Oil said it has refinanced its USD330 million Norwegian exploration loan facility, increaing the facility to USD500 million and extending the loan availability to the end of 2017. The FTSE 100 oil and gas exploration company said the arrangement replaces a previous facility arranged by Spring Energy before it was acquired by Tullow Oil in January 2013. It was due to expire in December 2014.
----------
GlaxoSmithKline said a late stage study of its drug eltrombopag for the treatment of chronic immune thrombocytopenia in paediatric patients had met its primary endpoint. Immune thrombocytopenia is a bleeding disorder where the blood does not clot properly. The drug, which its marketed as Promacta in the US and Revolade in Europe, showed a statistically significant improvement in platelet counts compared to a placebo.
----------
AstraZeneca said late Thursday that the US Food and Drug Administration's Analgesic Drug Products Advisory Committee has recommended the FDA not require cardiovascular outcomes trials for a class of drugs including AstraZeneca's movantix treatment. Movantix is a mu-opioid receptor antagonist for the treatment of opioid-induced constipation in patients with chronic non-cancer pain. Opioids assist with chronic pain relief by binding mu-receptors in the brain, but also bind nu-receptors in the bowel, which means patients taking opioids for chronic pain can develop opioid-induced constipation.
----------
UK women's clothing retailer Bonmarche Holdings reported strong profit and sales growth in its most recent financial year, driven by market share gains, price increases and growth in its online business. In its maiden results as a listed company, the clothing retailer targeting women over 50 years old reported a pretax profit of GBP11.2 million for the financial year ended March 29, up from GBP6.1 million a year earlier, as the company posted a 12% increase in revenues to GBP164.3 million, from GBP146.8 million. Like-for-like sales also grew strongly, up more than 10%. The retailer declared its first dividend of 2.1 pence per share for the year.
----------
AIM MOVERS
----------
SyQic is a big gainer after it said its main mobile streaming business, YooMob, booked revenue of GBP2.0 million in the first quarter to end-March, and had experienced encouraging trading in the two subsequent months, with total revenue of GBP1.6 million in April and May. SyQic expects the "upward trend" in revenue to continue during the rest of the year. Cientifica is also up after it entered into a development agreement with UK based Perpetuus Carbon Group in the hope of speeding up the production of its graphene products. Perpetuus produces nano surface modified graphenes. Under the collaboration Perpetuus will provide technical support for Cientifica's product development to bring them to market quicker. No financial details were disclosed. Tower Resources has lost two-thirds of its value after it failed to find hydrocarbons in early targets at the Welwitschia-1A well on the PEL0010 licence offshore Namibia, and had to stop drilling deeper due to spiralling costs. The well is being plugged and abandoned. ViaLogy is another big faller after it became a molecular diagnostic company by buying Premaitha for GBP10.5 million, although it had to write down the value of the energy services business it is trying to offload because it is taking longer than it hoped to find a "suitable" partner for that business. It said it would pay for Premaitha by issuing 95.5 million new shares at 11 pence each, and that it had raised GBP6.5 million by placing 59.1 million new shares at the same price. It also launched an open offer of up to 6.7 million more new shares at the same price. It is also planning a 100-for-1 share consolidation, because it thinks it will benefit from having fewer shares in issue and trading in pence rather than fractions of a pence. It will change its name to Premaitha Health. Transense Technologies is down after it said it now expects to post a loss before interest, tax, depreciation and amortisation for its current financial year, albeit a narrower loss than last year, after it experienced delays in getting some new orders. It said it expects its revenue in the year to end-June to be no less that GBP3.5 million, up from GBP1.5 million a year earlier, but that is lower that it had expected when it put out its interim results in February. The company had previously expected to breakeven at the Ebitda level in the current financial year, but said the revenue shortfall compared with previous expectations means it will now make a loss.
----------
Top Economics And General
----------
Sunni militants have captured at least one town in eastern Iraq, broadening their domination over portions of the country as they press south toward the capital Baghdad, reports said. Their lightning advances have sparked international fears that Iraq is falling apart, making room for the emergence of a radical enclave. Fighters from the radical Islamic State in Iraq and the Levant (ISIL), backed by local insurgents, seized the town of Jalula, 125 kilometres north-east of Baghdad, Dubai-based broadcaster Al Arabiya said. However, local officials said Jalula was under the control of Peshmerga - military troops of Kurdistan - after government forces abandoned their outposts in the town.
----------
The US is not considering sending troops into Iraq to stop advances by Islamist militants, a State Department spokeswoman said. Describing the situation as "alarming" and saying there has been a "clear structural breakdown" in Iraq, spokeswoman Jen Psaki said the US and Iraq "share a commitment to addressing threats from groups such as ISIL." Psaki spoke at a briefing after US President Barack Obama said his administration was "looking at all options" on how to respond to the latest violence in Iraq.
----------
Bank of England governor Mark Carney signalled that interest rate could rise sooner than forecast, due to strong economic growth. In a speech at the annual Mansion House in the City of London to financial and political leaders on Thursday, the governor said that interest rate "could happen sooner than markets currently expect." "There's already great speculation about the exact timing of the first rate hike and this decision is becoming more balanced. However, the decision would be dependent on data and is not a pre-set course", he added. There remains more spare capacity in the economy that would need to be used up first, he said.
----------
Fitch Ratings affirmed the sovereign ratings of the UK with 'stable' outlook, citing its favourable macroeconomic trends. The long-term ratings were maintained at 'AA+'. Strong GDP growth, falling unemployment and inflation close to the 2% target continued in the economy since the last review in December 2013, Fitch said.
----------
Fitch Ratings has also lowered South Africa's credit rating outlook to Negative from Stable, citing deterioration in growth prospects amid rising labor strike activity in the country.
----------
The Bank of Japan retained its monetary policy unchanged while raising its view on overseas growth. The policy board of the BoJ unanimously decided to increase the monetary base at an annual pace of about JPY60-JPY70 trillion as widely expected by economists. "Overseas economies -- mainly advanced economies -- are recovering, albeit with a lackluster performance still seen in part," the bank said. With regard to the Japan outlook, the bank said the economy is expected to continue a moderate recovery as a trend, while it will be affected by the subsequent decline in demand following the front-loaded increase prior to the consumption tax hike.
----------
EU Energy Commissioner Guenther Oettinger says he expects gas talks between Russia and Moscow to resume on Saturday. "My hope is that we can continue tomorrow," he told journalists on the margins of an EU energy ministers' meeting in Luxembourg, adding that he expects Ukraine and Russia to be represented by their energy ministers and the chiefs of their respective gas companies. He said he is flexible on the location, whether it be "Brussels or Berlin or Kiev or Moscow."
----------
Ukraine said late Thursday that separatists in eastern Ukraine had obtained heavy armour from neighbouring Russia. Pro-Russian militants had brought at least three tanks across the border, Interior Minister Arsen Avakov told journalists in Kiev. President Petro Poroshenko had voiced "extreme concern" over the tanks and the wider clashes in eastern Ukraine, in a phone call, said European Commission President Jose Manuel Barroso, speaking at a press conference in Georgia. Moscow made no immediate comment.
----------
Neymar's two goals, some help from the Japanese referee, and big support from the local fans have given hosts Brazil the perfect start to the World Cup. The 3-1 victory over Croatia in the tournament opener Thursday sparked widespread celebrations in the country, and coach Luiz Felipe Scolari is relieved that his team can book a place in the last 16 as early as Tuesday if they beat Mexico, and other results go their way. "This victory gives us a chance to breathe and another victory gives me room to breathe," Scolari said, describing his players as excellent.
---------
Afternoon Watchlist (all times British Summer Time)
---------

13:30 US Producer Price Index
14:55 US Reuters/Michigan Consumer Sentiment Index Preliminary

---------
Monday's Key UK Corporate Events
---------

Picton Property Income Full Year Results
F&C Global Smaller Companies Full Year Results
Majestic Wine Full Year Results
RM2 International Full Year Results

---------
Monday's Key Economic Events (all times British Summer Time)
---------

00:01 UK BoE Quarterly Bulletin
00:01 UK Rightmove House Price Index
06:00 Japan BoJ Monthly Economic Survey
10:00 EU Consumer Price Index
13:30 US NY Empire State Manufacturing Index
14:15 US Industrial Production
15:00 US NAHB Housing Market Index

---------

Contact: +44 203 668 7440; newsroom@alliancenews.com; @AllNewsTeam

Copyright 2014 Alliance News Limited. All Rights Reserved.

More News
1 Feb 2024 09:03

LONDON BROKER RATINGS: Barclays cuts Next; JPMorgan raises easyJet

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
1 Feb 2024 07:42

LONDON BRIEFING: Shell profit falls; announces USD3.5 billion buyback

(Alliance News) - Stocks in London are set to follow New York into the red, after the US Federal Reserve quashed hopes of a March cut to interest rates and ahead of the Bank of England interest rate decision.

Read more
31 Jan 2024 17:05

LONDON MARKET CLOSE: Stocks mixed hours before expected US Fed hold

(Alliance News) - Stock prices in London closed mixed on Wednesday in a trade-thinned day ahead of the US Federal Reserve interest rate decision this evening.

Read more
31 Jan 2024 15:49

London close: Stocks mixed ahead of US Fed, BoE decisions

(Sharecast News) - London's financial markets finished with mixed performance on Wednesday, with investors closing their wallets ahead of rate announcements from both the US Federal Reserve and the Bank of England.

Read more
31 Jan 2024 12:05

LONDON MARKET MIDDAY: FTSE 100 flat ahead of Federal Reserve decision

(Alliance News) - The FTSE 100 in London was flat heading into Wednesday afternoon, as the US Federal Reserve's latest interest rate decision edges closer, keeping equity market enthusiasm to a minimum.

Read more
31 Jan 2024 09:13

TOP NEWS: GSK profit up on Arexvy boost in 2023 but total payout down

(Alliance News) - GSK PLC reported an increase in profit and revenue for 2023 as revenue for HIV medicine had stable growth, amid optimism in the company's outlook.

Read more
31 Jan 2024 08:55

LONDON MARKET OPEN: Stocks lack direction ahead of Fed, BoE

(Alliance News) - Stock prices in London lacked direction at the open on Wednesday, as investors nervously look ahead to interest rate decisions from the US Federal Reserve and Bank of England.

Read more
31 Jan 2024 07:46

LONDON BRIEFING: Stocks called up; GSK revenue and profit up

(Alliance News) - Stocks in London are called to open higher, as markets share of nerves around the next set of interest rate decisions.

Read more
29 Jan 2024 08:51

GSK seeks expanded use of RSV vaccine in EU, wins approval for Omjjara

(Alliance News) - GSK PLC on Monday celebrated regulatory progress for two of its products in the EU.

Read more
29 Jan 2024 07:43

LONDON BRIEFING: Superdry looks at saving costs; Ferrexpo loses case

(Alliance News) - Stocks in London are expected to start the week on a cautious note, as investors nervously look ahead to two key interest rate decisions.

Read more
29 Jan 2024 07:07

GSK gets EU approval to sell blood cancer treatment Omijara

(Sharecast News) - Biopharma giant GSK has been given the green light by European regulators to sell Omjjara, its treatment for patients with a rare type of blood cancer.

Read more
26 Jan 2024 10:47

Citi hikes target price for GSK but stays 'neutral'

(Sharecast News) - Shares in biopharma giant GSK were rising on Friday, helped by forecast upgrades from Citi, which raised its target price on the stock from 1,535p to 1,700p.

Read more
24 Jan 2024 15:08

Private equity firm Yellow Wood close to deal to acquire ChapStick-sources

Jan 24 (Reuters) - Private equity firm Yellow Wood Partners is in advanced talks to acquire ChapStick, a lip balm brand, from Haleon Plc, the former consumer health division of drug developer GSK Plc, four people familiar with the matter said.

Read more
24 Jan 2024 14:34

UK earnings, trading statements calendar - next 7 days

Thursday 25 January 
Britvic PLCTrading Statement
Conduit Holdings LtdTrading Statement
CVS Group PLCTrading Statement
Dr Martens PLCTrading Statement
Fevertree Drinks PLCTrading Statement
Foxtons Group PLCFull Year Results
Fuller, Smith & Turner PLCTrading Statement
Halfords Group PLCTrading Statement
Idox PLCFull Year Results
IG Group Holdings PLCHalf Year Results
Intermediate Capital Group PLCTrading Statement
Mitie Group PLCTrading Statement
NCC Group PLCHalf Year Results
Newmark Security PLCHalf Year Results
Next 15 Group PLCTrading Statement
PPHE Hotel Group LtdTrading Statement
Secure Trust Bank PLCTrading Statement
St James's Place PLCTrading Statement
Time Finance PLCHalf Year Results
Titon Holdings PLCFull Year Results
Wizz Air Holdings PLCQ3 Results
Workspace Group PLCTrading Statement
Friday 26 January 
Paragon Banking Group PLCTrading Statement
Record PLCTrading Statement
Superdry PLCHalf Year Results
Taylor Maritime Investments LtdTrading Statement
WH Smith PLCTrading Statement
YouGov PLCTrading Statement
Monday 29 January 
Team Internet Group PLCTrading Statement
Tuesday 30 January 
Diaceutics PLCTrading Statement
Diageo PLCHalf Year Results
Kromek Group PLCHalf Year Results
Luceco PLCTrading Statement
Oxford Cannabinoid Technologies Holdings PLCHalf Year Results
Pets at Home Group PLCTrading Statement
Renewi PLCTrading Statement
Saga PLCTrading Statement
SSP Group PLCTrading Statement
SThree PLCFull Year Results
Synthomer PLCTrading Statement
Wednesday 31 January 
Aberforth Smaller Companies Trust PLCFull Year Results
abrdn Private Equity Opportunities Trust PLCFull Year Results
Ecora Resources PLCTrading Statement
GSK PLCFull Year Results
ITM Power PLCHalf Year Results
NWF Group PLCHalf Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
22 Jan 2024 21:22

Fate of most remaining Zantac lawsuits weighed by Delaware judge

Jan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies are urging a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.